Saga Publications
Independent Press
View Rights PortalYour Search Results
-
-
il Saggiatore
Established by Alberto Mondadori in 1958, il Saggiatore is an independent publishing house focused on literary fiction and non-fiction, with a particular emphasis on science, history and economics. Our wide-ranging non-fiction list comprises the likes of Claude Lévi-Strauss, Jean-Paul Sartre, Fernand Braudel, Noam Chomsky, Howard Zinn, Nassim Nicholas Taleb, Daron Acemoglu, Paul Mason, Jaron Lanier, Joseph Mazur, Mark Cousins and Piero Camporesi, among others. Our ever-growing literary fiction list includes Allen Ginsberg, Witold Gombrowicz, Joan Didion, Geoff Dyer, Olivia Laing, Esther Kinsky, Mircea Cărtărescu, László Darvasi, Akwaeke Emezi, Emma Glass, Mike McCormack and David Peace, to name just a few. Shortly after the birth of the publishing house, speaking to an Italian newspaper, Alberto Mondadori said: “I’m an explorer, I like to travel in time”. Sixty years later, his words and his vision live on, and il Saggiatore’s project is still the same: to publish books that can stand the test of time.
View Rights Portal
-
Handicrafts, decorative arts & craftsSeptember 2020Beautiful cut & display papercut art in five colors
by Ayano Sagawa
253 designs of animals, flowers, nature, and seasonal decorations, printed on high quality paper in five different colors, ready to cut out and display as you wish. The designs are also printed on regular paper, so that you can transfer them to the paper of your choice and reuse them as many times as you like.
-
How to Draw and Write in Fountain Pen
A Modern Guide
by Ayano Usamura
Unlock your creativity and put your own signature touches on cards, crafts, decorations and more with this modern guide to drawing with fountain pens. Easy-to-follow steps will have you drawing 70 charming designs in no time. Pull-out practice paper, a mini tracing booklet and a built-in pocket make this the perfect package to get you started! #HowToFountainPen
-
June 2018Urbanization and Slums
Infectious Diseases in the Built Environment: Proceedings of a Workshop
by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Global Health, Forum on Microbial Threats, Anna Nicholson, Cecilia Mundaca Shah, V. Ayano Ogawa
The urban built environment is a prime setting for microbial transmission, because just as cities serve as hubs for migration and international travel, components of the urban built environment serve as hubs that drive the transmission of infectious disease pathogens. The risk of infectious diseases for many people living in slums is further compounded by their poverty and their surrounding physical and social environment, which is often overcrowded, is prone to physical hazards, and lacks adequate or secure housing and basic infrastructure, including water, sanitation, or hygiene services. To examine the role of the urban built environment in the emergence and reemergence of infectious diseases that affect human health, the National Academies of Sciences, Engineering, and Medicine planned a public workshop. This publication summarizes the presentations and discussions from the workshop.
-
MedicineJuly 2017Building Communication Capacity to Counter Infectious Disease Threats
Proceedings of a Workshop
by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Global Health, Forum on Microbial Threats, Joe Alper, Ceci Mundaca-Shah, V. Ayano Ogawa
Building communication capacity is a critical piece of preparing for, detecting, and responding to infectious disease threats. The International Health Regulations (IHR) establish risk communicationâ€"the real-time exchange of information, advice, and opinions between experts or officials and people who face a threat to their survival, health, and economic or social well-beingâ€"as a core capacity that World Health Organization member states must fulfill to strengthen the fight against these threats. Despite global recognition of the importance of complying with IHR, 67 percent of signatory countries report themselves as not compliant. By investing in communication capacity, public health and government officials and civil society organizations facing health crises would be prepared to provide advice, information, and reassurance to the public as well as to rapidly develop messages and community engagement activities that are coordinated and take into account social and behavioral dynamics among all sectors. To learn about current national and international efforts to develop the capacity to communicate effectively during times of infectious disease outbreaks, and to explore gaps in the research agenda that may help address communication needs to advance the field, the Forum on Microbial Threats of the National Academies of Sciences, Engineering, and Medicine convened a 1.5 day workshop on December 13 and 14, 2016, in Washington, DC. Participants reviewed progress and needs in strengthening communication capacity for dealing with infectious disease threats for both outbreaks and routine challenges in the United States and abroad. This publication summarizes the presentations and discussions from the workshop.
-
MedicineDecember 2017Combating Antimicrobial Resistance
A One Health Approach to a Global Threat: Proceedings of a Workshop
by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Global Health, Forum on Microbial Threats, Anna Nicholson, V. Ayano Ogawa, Ceci Mundaca-Shah
As of 2017, the emergence and spread of antimicrobial resistance continues unabated around the world, leaving devastating health and economic outcomes in its wake. Those consequences will multiply if collaborative global action is not taken to address the spread of resistance. Major drivers of antimicrobial resistance in humans have been accelerated by inappropriate antimicrobial prescribing in health care practices; the inappropriate use of antimicrobials in livestock; and the promulgation of antibiotic resistance genes in the environment. To explore the issue of antimicrobial resistance, the Forum of Microbial Threats planned a public workshop. Participants explored issues of antimicrobial resistance through the lens of One Health, which is a collaborative approach of multiple disciplines - working locally, nationally, and globally - for strengthening systems to counter infectious diseases and related issues that threaten human, animal, and environmental health, with an end point of improving global health and achieving gains in development. They also discussed immediate and short-term actions and research needs that will have the greatest effect on reducing antimicrobial resistance, while taking into account the complexities of bridging different sectors and disciplines to address this global threat. This publication summarizes the presentations and discussions from the workshop.
-
Public health & preventive medicineJuly 2015Assessing the Use of Agent-Based Models for Tobacco Regulation
by Robert Wallace, Amy Geller, V. Ayano Ogawa, Editors; Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation; Board on Population Health and Public Health Practice; Institute of Medicine
Tobacco consumption continues to be the leading cause of preventable disease and death in the United States. The Food and Drug Administration (FDA) regulates the manufacture, distribution, and marketing of tobacco products - specifically cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco - to protect public health and reduce tobacco use in the United States. Given the strong social component inherent to tobacco use onset, cessation, and relapse, and given the heterogeneity of those social interactions, agent-based models have the potential to be an essential tool in assessing the effects of policies to control tobacco. Assessing the Use of Agent-Based Models for Tobacco Regulation describes the complex tobacco environment; discusses the usefulness of agent-based models to inform tobacco policy and regulation; presents an evaluation framework for policy-relevant agent-based models; examines the role and type of data needed to develop agent-based models for tobacco regulation; provides an assessment of the agent-based model developed for FDA; and offers strategies for using agent-based models to inform decision making in the future.
